3 August 2018 - There have been aspirations for closer collaboration between European Union Member States on health technology assessment for at least two decades. 

In January 2018 the European Commission (EC) put forward it’s most ambitious proposals yet for members states (MS) to work together.

The EC has set out a number of ambitions for how a more – but not fully centralised – collaborative approach to HTA could help MS. They have a vision where there will be more HTAs done, for less, making better decisions, making business easier for industry, better informing patients, and ultimately getting patients faster access to new medicines. Such a prize is therefore something that the Commission believes is worth pursuing, despite a plethora of approaches across MS.

Read Pharmaphorum article